The final week of August brought two new FDA approvals for Parkinson's medications. MYOBLOC (rimabotulinumtoxinB) - a botulinum toxin type B, was indicated for the treatment of chronic…
Monika Sawdy, RN, MSN-LAugust 31, 2019
© PMD Alliance 2021 All Rights Reserved.